Clinical Trial Update: ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)

View source ↗

Summary

Clinical trial update analyzing ALK rearrangements in lung adenocarcinoma; focusing on epidemiology in Latin America.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Lung Cancer | Status: UNKNOWN